Teva Targets Apotex Over Generic Parkinson's Drug

Law360, New York (June 23, 2011, 8:39 PM EDT) -- Teva Pharmaceutical Industries Ltd. sued Apotex Corp. for patent infringement in Florida on Wednesday over its efforts to make a generic version of Parkinson's disease treatment Azilect.

The Israeli pharmaceutical company and its units say Apotex infringed a patent by filing an abbreviated new drug application with the U.S. Food and Drug Administration for its own version of the oral Parkinson's treatment.

The Canadian generics maker sent Teva a letter in May about filing the application, which said the patent — U.S. Patent Number 5,453,446 —...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.